The risk of recurrent stroke was not reduced in the dual antiplatelet group , @ % per year , compared to the aspirin-only group , @ % per year ( hazard ratio -LSB- HR -RSB- @ ; @ % confidence interval -LSB- CI -RSB- @-@ @ ) .